The initial, perhaps overly simplistic, expectation was that liver disease would lead to decreased ADA activity; this directional change in M4 was thus unanticipated but suggests an increase in ADA activity and/or expression, possibly due to inflammation and/or metabolic or immune dysfunction. Here, ADA is linked to immune system disorder.